Sugi Predict

Sugi Predict / Compounds / SCHEMBL31681

SCHEMBL31681

SCHEMBL31681

Cc1ccc(-n2c3ccccc3c3cc4c(cc32)C(C)(C)c2ccccc2-4)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 4/20 0.42
▸ KDM4E B2RXH2 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ TP53 P04637 1/20 0.34
▸ PDK2 Q15119 3/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ AKR1C4 P17516 1/20 0.32
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ AKR1C1 Q04828 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ LIG1 P18858 1/20 0.31
▸ METAP2 P50579 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14849805 0.95 KDM4E (0.43) PGRKDM4EL3MBTL1ATMMAPT
SCHEMBL14822435 0.95 KDM4E (0.43) PGRKDM4EL3MBTL1ATMMAPT
SCHEMBL802718 0.95 KDM4E (0.43) PGRKDM4EL3MBTL1ATMMAPT
SCHEMBL16882969 0.91 PGR (0.37) PGRKDM4EL3MBTL1ATMLMNA
SCHEMBL14849709 0.91 KDM4E (0.40) PGRKDM4EL3MBTL1ATMAKR1C4
SCHEMBL17038422 0.91 KDM4E (0.40) PGRKDM4EL3MBTL1ATM
SCHEMBL14822535 0.91 KDM4E (0.40) PGRKDM4EL3MBTL1ATMAKR1C4
SCHEMBL783257 0.91 KDM4E (0.40) PGRKDM4EL3MBTL1ATMAKR1C4
SCHEMBL14849722 0.91 KDM4E (0.47) PGRKDM4EL3MBTL1ATMKMT2A
SCHEMBL14852904 0.91 PGR (0.43) PGRKDM4EHTTTP53PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 — — US disclosed
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 — — US disclosed
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 — — US disclosed
US-11832513-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-11-28 — — US disclosed
EP-4242286-A2 MATERIALS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2023-09-13 — — EP disclosed
EP-3714022-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2023-06-07 — — EP disclosed
US-20210376256-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2021-12-02 — — US disclosed
US-20200303654-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-09-24 — — US disclosed
US-20190280218-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2019-09-12 — — US disclosed
US-10374170-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2019-08-06 — — US disclosed
US-8906893-B2 Substituted tetraarylbenzenes MERCK PATENT GMBH (DE) 2014-12-09 — — US disclosed
US-8906893-B2 Substituted tetraarylbenzenes MERCK PATENT GMBH (DE) 2014-12-09 — — US disclosed
US-20130261708-A1 SUBSTITUTED TETRAARYLBENZENES MERCK PATENT GMBH (DE) 2013-10-03 — — US disclosed
US-20130261708-A1 SUBSTITUTED TETRAARYLBENZENES MERCK PATENT GMBH (DE) 2013-10-03 — — US disclosed
US-20130253617-A1 PHOSPHORUS-CONTAINING METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-09-26 — — US disclosed
US-20130253617-A1 PHOSPHORUS-CONTAINING METAL COMPLEXES MERCK PATENT GMBH (DE) 2013-09-26 — — US disclosed
WO-2012107163-A1 SUBSTITUTED DIBENZONAPHTHACENE MERCK PATENT GMBH (DE) 2012-08-16 — — WO disclosed
WO-2012079678-A1 SUBSTITUTED TETRAARYLBENZENES MERCK PATENT GMBH (DE) 2012-06-21 — — WO disclosed
WO-2012038029-A1 PHOSPHORUS-CONTAINING METAL COMPLEXES MERCK PATENT GMBH (DE) 2012-03-29 — — WO disclosed
WO-2012026780-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2012-03-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11832513-B2 Materials for electronic devices PNMT, DDT, COMT PGR 1469/4885KDM4E 3302/4885L3MBTL1 3148/4885
US-11917913-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 PGR 1812/4885KDM4E 710/4885L3MBTL1 1480/4885
US-10374170-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 PGR 1812/4885KDM4E 710/4885L3MBTL1 1480/4885
US-20210376256-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OSBP PGR 2693/4885KDM4E 1586/4885L3MBTL1 652/4885
US-20190280218-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 PGR 1812/4885KDM4E 710/4885L3MBTL1 1480/4885
US-20200303654-A1 MATERIALS FOR ELECTRONIC DEVICES PNMT, DDT, COMT PGR 1469/4885KDM4E 3302/4885L3MBTL1 3148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.